GURUFOCUS.COM » STOCK LIST » Communication Services » Media - Diversified » Pervasip Corp (OTCPK:PVSP) » Definitions » Sloan Ratio %

Pervasip (Pervasip) Sloan Ratio % : 0.00% (As of Aug. 2023)


View and export this data going back to . Start your Free Trial

What is Pervasip Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Pervasip's Sloan Ratio for the quarter that ended in Aug. 2023 was 0.00%.

Warning Sign:

When sloan ratio (252.13)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.

As of Aug. 2023, Pervasip has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Pervasip Sloan Ratio % Historical Data

The historical data trend for Pervasip's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pervasip Sloan Ratio % Chart

Pervasip Annual Data
Trend Nov06 Nov07 Nov08 Nov09 Nov10 Nov11 Nov12 Nov13 Nov14 Nov15
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 252.13

Pervasip Quarterly Data
May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Aug22 Aug23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pervasip's Sloan Ratio %

For the Advertising Agencies subindustry, Pervasip's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pervasip's Sloan Ratio % Distribution in the Media - Diversified Industry

For the Media - Diversified industry and Communication Services sector, Pervasip's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Pervasip's Sloan Ratio % falls into.



Pervasip Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Pervasip's Sloan Ratio for the fiscal year that ended in Nov. 2015 is calculated as

Sloan Ratio=(Net Income (A: Nov. 2015 )-Cash Flow from Operations (A: Nov. 2015 )
-Cash Flow from Investing (A: Nov. 2015 ))/Total Assets (A: Nov. 2015 )
=(0.486--0.592
--0.044)/0.445
=252.13%

Pervasip's Sloan Ratio for the quarter that ended in Aug. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Aug. 2023 )
=(-1.586--0.158
-0)/11.845
=-12.06%

Pervasip's Net Income for the trailing twelve months (TTM) ended in Aug. 2023 was -0.493 (May. 2016 ) + -0.454 (Aug. 2016 ) + -0.088 (Aug. 2022 ) + -0.551 (Aug. 2023 ) = $-1.59 Mil.
Pervasip's Cash Flow from Operations for the trailing twelve months (TTM) ended in Aug. 2023 was -0.05 (May. 2016 ) + -0.108 (Aug. 2016 ) + 0 (Aug. 2022 ) + 0 (Aug. 2023 ) = $-0.16 Mil.
Pervasip's Cash Flow from Investing for the trailing twelve months (TTM) ended in Aug. 2023 was 0 (May. 2016 ) + 0 (Aug. 2016 ) + 0 (Aug. 2022 ) + 0 (Aug. 2023 ) = $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pervasip  (OTCPK:PVSP) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Aug. 2023, Pervasip has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Pervasip Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Pervasip's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pervasip (Pervasip) Business Description

Traded in Other Exchanges
N/A
Address
1917 1st Avenue, Suite 400, Seattle, WA, USA, 98101
Pervasip Corp principal activities of Company are consulting, IP licensing, management, staffing, leasing, and support services. It is a diversified asset management company that was founded to acquire, develop, and support companies and technologies in the emerging cannabis industry. It also, own the rights to a cannabis brand.
Executives
Kevin Kreisler other: Officer of subsidiary P.O. BOX 284, MT. ARLINGTON NJ 07856
Flux Carbon Corp 10 percent owner 5950 SHILOH ROAD EAST, SUITE N, ALPHARETTA GA 30005
Scott Robert Widham director BROADWING CORPORATION, 1122 CAPITAL OF TEXAS HIGHWAY SOUTH, AUSTIN TX 78746
Cherian Mathai director 2-01 50TH STREET, APARTMENT 4 C, LONG ISLAND CITY NY 11101
S Miller Williams director C/O WILLBROS USA INC, 4400 POST OAK PARKWAY SUITE 1000, HOUSTON TX 77027
Gayle L Greer director P O BOX 840 STE 300, DENVER CO 80201
Michael H Khalilian director, officer: Chief Technology Officer 478 E. ALTAMONTE DRIVE, SUITE 108-480, ALTAMONTE SPRINGS FL 32701
Mark Richards other: President of subsidiary 118 CELEBRATION BLVD., CELEBRATION FL 34747
Greg M Cooper director
Paul H Riss director, officer: Chief Executive Officer, other: Chief Financial Officer
Joel Dupre director C/O CORDIA CORP, 445 HAMILTON AVENUE, SUITE 408, WHITE PLAINS NY 10601

Pervasip (Pervasip) Headlines

From GuruFocus

Pervasip Corp at Emerging Growth Conference Transcript

By GuruFocus Research 02-14-2024

Pervasip Corp at Emerging Growth Conference Transcript

By GuruFocus Research 02-14-2024